Laparoendoscopic single-site surgeries: A single-center experience of 171 consecutive cases

Kyung Hwa Choi, Won Sik Ham, KoonHo Rha, Jae Won Lee, Hwang Gyun Jeon, Francis Raymond P Arkoncel, Seung Choul Yang, WoongKyu Han

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Purpose: We report our experience to date with 171 patients who underwent laparoendoscopic single-site surgery for diverse urologic diseases in a single institution. Materials and Methods: Between December 2008 and August 2010, we performed 171 consecutive laparoendoscopic single-site surgeries. These included simple nephrectomy (n=18; robotic surgeries, n=1), radical nephrectomy (n=26; robotic surgeries, n=2), partial nephrectomy (n=59; robotic surgeries, n=56), nephroureterectomy (n=20; robotic surgeries, n=12), pyeloplasty (n=4), renal cyst decortications (n=22), adrenalectomy (n=4; robotic surgeries, n=2), ureterolithotomy (n=10), partial cystectomy (n=3), ureterectomy (n=1), urachal mass excision (n=1), orchiectomy (n=1), seminal vesiculectomy (n=1), and retroperitoneal mass excision (n=1). All procedures were performed by use of a homemade single-port device with a wound retractor and surgical gloves. A prospective study was performed to evaluate outcomes in 171 cases. Results: Of the 171 patients, 98 underwent conventional laparoendoscopic single-site surgery and 73 underwent robotic laparoendoscopic single-site surgery. Mean patient age was 53 years, mean operative time was 190.8 minutes, and mean estimated blood loss was 204 ml. Intraoperative complications occurred in seven cases (4.1%), and post-operative complications in nine cases (5.3%). There were no complications classified as Grade IIIb or higher (Clavien-Dindo classification for surgical complications). Conversion to mini-incision open surgery occurred in seven (4.1%) cases. Regarding oncologic outcomes, no cancer-related events occurred during follow-up other than one aggressive progression of Ewing sarcoma. Conclusions: Laparoendoscopic single-site surgery is technically feasible and safe for various urologic diseases; however, surgical experience and long-term follow-up are needed to test the superiority of laparoendoscopic single-site surgery.

Original languageEnglish
Pages (from-to)31-38
Number of pages8
JournalKorean Journal of Urology
Volume52
Issue number1
DOIs
Publication statusPublished - 2011 Jan 1

Fingerprint

Robotics
Nephrectomy
Urologic Diseases
Surgical Gloves
Ewing's Sarcoma
Orchiectomy
Cystectomy
Adrenalectomy
Intraoperative Complications
Operative Time
Cysts
Prospective Studies
Kidney
Equipment and Supplies
Wounds and Injuries
Neoplasms

All Science Journal Classification (ASJC) codes

  • Urology

Cite this

Choi, Kyung Hwa ; Ham, Won Sik ; Rha, KoonHo ; Lee, Jae Won ; Jeon, Hwang Gyun ; Arkoncel, Francis Raymond P ; Yang, Seung Choul ; Han, WoongKyu. / Laparoendoscopic single-site surgeries : A single-center experience of 171 consecutive cases. In: Korean Journal of Urology. 2011 ; Vol. 52, No. 1. pp. 31-38.
@article{04a4c86bbb2447e68cbe79596293983a,
title = "Laparoendoscopic single-site surgeries: A single-center experience of 171 consecutive cases",
abstract = "Purpose: We report our experience to date with 171 patients who underwent laparoendoscopic single-site surgery for diverse urologic diseases in a single institution. Materials and Methods: Between December 2008 and August 2010, we performed 171 consecutive laparoendoscopic single-site surgeries. These included simple nephrectomy (n=18; robotic surgeries, n=1), radical nephrectomy (n=26; robotic surgeries, n=2), partial nephrectomy (n=59; robotic surgeries, n=56), nephroureterectomy (n=20; robotic surgeries, n=12), pyeloplasty (n=4), renal cyst decortications (n=22), adrenalectomy (n=4; robotic surgeries, n=2), ureterolithotomy (n=10), partial cystectomy (n=3), ureterectomy (n=1), urachal mass excision (n=1), orchiectomy (n=1), seminal vesiculectomy (n=1), and retroperitoneal mass excision (n=1). All procedures were performed by use of a homemade single-port device with a wound retractor and surgical gloves. A prospective study was performed to evaluate outcomes in 171 cases. Results: Of the 171 patients, 98 underwent conventional laparoendoscopic single-site surgery and 73 underwent robotic laparoendoscopic single-site surgery. Mean patient age was 53 years, mean operative time was 190.8 minutes, and mean estimated blood loss was 204 ml. Intraoperative complications occurred in seven cases (4.1{\%}), and post-operative complications in nine cases (5.3{\%}). There were no complications classified as Grade IIIb or higher (Clavien-Dindo classification for surgical complications). Conversion to mini-incision open surgery occurred in seven (4.1{\%}) cases. Regarding oncologic outcomes, no cancer-related events occurred during follow-up other than one aggressive progression of Ewing sarcoma. Conclusions: Laparoendoscopic single-site surgery is technically feasible and safe for various urologic diseases; however, surgical experience and long-term follow-up are needed to test the superiority of laparoendoscopic single-site surgery.",
author = "Choi, {Kyung Hwa} and Ham, {Won Sik} and KoonHo Rha and Lee, {Jae Won} and Jeon, {Hwang Gyun} and Arkoncel, {Francis Raymond P} and Yang, {Seung Choul} and WoongKyu Han",
year = "2011",
month = "1",
day = "1",
doi = "10.4111/kju.2011.52.1.31",
language = "English",
volume = "52",
pages = "31--38",
journal = "Korean Journal of Urology",
issn = "2005-6737",
publisher = "Korean Urological Association",
number = "1",

}

Laparoendoscopic single-site surgeries : A single-center experience of 171 consecutive cases. / Choi, Kyung Hwa; Ham, Won Sik; Rha, KoonHo; Lee, Jae Won; Jeon, Hwang Gyun; Arkoncel, Francis Raymond P; Yang, Seung Choul; Han, WoongKyu.

In: Korean Journal of Urology, Vol. 52, No. 1, 01.01.2011, p. 31-38.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Laparoendoscopic single-site surgeries

T2 - A single-center experience of 171 consecutive cases

AU - Choi, Kyung Hwa

AU - Ham, Won Sik

AU - Rha, KoonHo

AU - Lee, Jae Won

AU - Jeon, Hwang Gyun

AU - Arkoncel, Francis Raymond P

AU - Yang, Seung Choul

AU - Han, WoongKyu

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Purpose: We report our experience to date with 171 patients who underwent laparoendoscopic single-site surgery for diverse urologic diseases in a single institution. Materials and Methods: Between December 2008 and August 2010, we performed 171 consecutive laparoendoscopic single-site surgeries. These included simple nephrectomy (n=18; robotic surgeries, n=1), radical nephrectomy (n=26; robotic surgeries, n=2), partial nephrectomy (n=59; robotic surgeries, n=56), nephroureterectomy (n=20; robotic surgeries, n=12), pyeloplasty (n=4), renal cyst decortications (n=22), adrenalectomy (n=4; robotic surgeries, n=2), ureterolithotomy (n=10), partial cystectomy (n=3), ureterectomy (n=1), urachal mass excision (n=1), orchiectomy (n=1), seminal vesiculectomy (n=1), and retroperitoneal mass excision (n=1). All procedures were performed by use of a homemade single-port device with a wound retractor and surgical gloves. A prospective study was performed to evaluate outcomes in 171 cases. Results: Of the 171 patients, 98 underwent conventional laparoendoscopic single-site surgery and 73 underwent robotic laparoendoscopic single-site surgery. Mean patient age was 53 years, mean operative time was 190.8 minutes, and mean estimated blood loss was 204 ml. Intraoperative complications occurred in seven cases (4.1%), and post-operative complications in nine cases (5.3%). There were no complications classified as Grade IIIb or higher (Clavien-Dindo classification for surgical complications). Conversion to mini-incision open surgery occurred in seven (4.1%) cases. Regarding oncologic outcomes, no cancer-related events occurred during follow-up other than one aggressive progression of Ewing sarcoma. Conclusions: Laparoendoscopic single-site surgery is technically feasible and safe for various urologic diseases; however, surgical experience and long-term follow-up are needed to test the superiority of laparoendoscopic single-site surgery.

AB - Purpose: We report our experience to date with 171 patients who underwent laparoendoscopic single-site surgery for diverse urologic diseases in a single institution. Materials and Methods: Between December 2008 and August 2010, we performed 171 consecutive laparoendoscopic single-site surgeries. These included simple nephrectomy (n=18; robotic surgeries, n=1), radical nephrectomy (n=26; robotic surgeries, n=2), partial nephrectomy (n=59; robotic surgeries, n=56), nephroureterectomy (n=20; robotic surgeries, n=12), pyeloplasty (n=4), renal cyst decortications (n=22), adrenalectomy (n=4; robotic surgeries, n=2), ureterolithotomy (n=10), partial cystectomy (n=3), ureterectomy (n=1), urachal mass excision (n=1), orchiectomy (n=1), seminal vesiculectomy (n=1), and retroperitoneal mass excision (n=1). All procedures were performed by use of a homemade single-port device with a wound retractor and surgical gloves. A prospective study was performed to evaluate outcomes in 171 cases. Results: Of the 171 patients, 98 underwent conventional laparoendoscopic single-site surgery and 73 underwent robotic laparoendoscopic single-site surgery. Mean patient age was 53 years, mean operative time was 190.8 minutes, and mean estimated blood loss was 204 ml. Intraoperative complications occurred in seven cases (4.1%), and post-operative complications in nine cases (5.3%). There were no complications classified as Grade IIIb or higher (Clavien-Dindo classification for surgical complications). Conversion to mini-incision open surgery occurred in seven (4.1%) cases. Regarding oncologic outcomes, no cancer-related events occurred during follow-up other than one aggressive progression of Ewing sarcoma. Conclusions: Laparoendoscopic single-site surgery is technically feasible and safe for various urologic diseases; however, surgical experience and long-term follow-up are needed to test the superiority of laparoendoscopic single-site surgery.

UR - http://www.scopus.com/inward/record.url?scp=79551712781&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79551712781&partnerID=8YFLogxK

U2 - 10.4111/kju.2011.52.1.31

DO - 10.4111/kju.2011.52.1.31

M3 - Article

C2 - 21344028

AN - SCOPUS:79551712781

VL - 52

SP - 31

EP - 38

JO - Korean Journal of Urology

JF - Korean Journal of Urology

SN - 2005-6737

IS - 1

ER -